M-ALPHA

M-ALPHA, also known as 3,4-methylenedioxy-α-ethyl-N-methylbenzylamine or as α-ethyl-N-methylpiperonylamine, is a psychoactive drug of the substituted benzylamine group. It was reported by Alexander Shulgin in his book PIHKAL as a positional isomer of MDMA. Subsequently, the drug was encountered as a designer drug in the United Kingdom in 2010 and was reported to the EMCDDA new drug monitoring service. It was described by Shulgin as similar in action to its demethylated homologue, ALPHA, but with roughly twice the duration and twice the potency. ALPHA itself was described as active at doses of 10 to 140 mg, with a duration of about 3 hours, and producing eyes-closed "dreams", some body tingling, and a pleasant positive feeling, but without any appetite suppression. M-ALPHA was encountered as a designer drug by 2010.

Also known as: 1-methylamino-1-(3,4-methylenedioxy-phenyl)propane, methylenedioxy-alphaETHYL-phenMETHylamine

Classification

Chemical: Amphetamine
Psychoactive: Stimulant
Tag: Substituted amphetamine

Effects

Increased Heart Rate
Stimulation
Sweating
Loss Of Appetite
Increased Perspiration
Teeth Grinding
Talkativeness
Alertness Enhancement
Euphoria
Anxiety
Irritability
Wakefulness
Light Sensitivity
Increased Libido
Appetite Suppression
Dehydration
Disinhibition
Increased Music Appreciation

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu